| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Procaterol aldehyde Impurity |
5-ForMyl-8-羥基卡替丁 |
68304-21-2 |
詳細(xì)
|
| Brexpiprazole Impurity 36 |
依匹哌唑雜質(zhì)32氯化物 |
2760672-16-8 |
詳細(xì)
|
| Phenylpropylmethylamine Impurity 1 |
4-甲基亞硝胺基-1-3-吡啶基-1-丁酮 |
13256-11-6 |
詳細(xì)
|
| Benzbromarone Impurity 20 |
6-羥基-N,2-二甲基苯并呋喃-3-甲酰胺 |
638217-08-0 |
詳細(xì)
|
| Erlotinib Impurity 41 |
埃羅替尼雜質(zhì)2 |
1833220-19-6 |
詳細(xì)
|
| Etoricoxib Impurity 10 |
依托度昔布雜質(zhì)Ⅴ |
73312-69-3 |
詳細(xì)
|
| Esomeprazole Impurity H215/01 |
2-(((3,5-二甲基-4-氧化吡啶-2-基)甲基)亞磺?；?-5-甲氧基苯并[d]咪唑-1-鈉 |
1803449-15-1 |
詳細(xì)
|
| Vitamin A Impurity 9 |
維生素 A 棕櫚酸酯 |
79-81-2 |
詳細(xì)
|
| Entacapone Impurity 26 |
恩他卡朋雜質(zhì)71 |
1217439-96-7 |
詳細(xì)
|
| Pentoxyverine Impurity 16 |
1-苯基環(huán)戊烷甲酸乙酯 |
4535-95-9 |
詳細(xì)
|
| Butyphthalide impurity 13 |
丁苯酞 |
94704-90-2 |
詳細(xì)
|
| Omacycline Impurity 3 |
奧瑪環(huán)素雜質(zhì)11 |
2272886-35-6 |
詳細(xì)
|
| Methylprednisolone Hydrogen Succinate EP Impurity E |
潑尼松龍半琥珀酸酯 |
2920-86-7 |
詳細(xì)
|
| Olopatadine Impurity 3 |
鹽酸奧洛他定雜質(zhì)F |
113835-92-0 |
詳細(xì)
|
| Celecoxib Impurity 9 |
塞來(lái)昔布相關(guān)物質(zhì)B |
331943-04-5 |
詳細(xì)
|
| Lurasidone impurity 26 |
S,S-內(nèi)型魯拉西酮鹽酸鹽 |
1318074-27-9 |
詳細(xì)
|
| Trelagliptin Impurity P |
曲格列汀雜質(zhì) |
1812193-01-3 |
詳細(xì)
|
| Fluconazole Impurity 15 |
氟康唑雜質(zhì)5 |
154534-83-5 |
詳細(xì)
|
| Dydrogesterone Impurity 3 |
地屈孕酮雜質(zhì) C |
25093-47-4 |
詳細(xì)
|
| Cabozantinib impurity 34 |
卡博替尼雜質(zhì)DYH |
1621681-63-7 |
詳細(xì)
|
| Tetracaine N-Oxide |
鹽酸丁卡因氮氧化物 |
55750-02-2 |
詳細(xì)
|
| Lobeline Impurity 6 |
|
888711-33-9 |
詳細(xì)
|
| Iopamidol EP Impurity H |
碘帕醇雜質(zhì)III |
2996862-55-4 |
詳細(xì)
|
| Rizatriptan Impurity |
利扎曲普坦雜質(zhì)C |
208941-96-2 |
詳細(xì)
|
| Ruxolitinib Impurity 3 |
1H-吡唑-1-丙腈,Β-環(huán)戊基-4-[7-(羥基甲基)-7H-吡咯并[2,3-D]嘧啶-4-基]-,(ΒR)- |
1236033-03-6 |
詳細(xì)
|
| Irbesartan Impurity 11 |
厄貝沙坦雜質(zhì) |
158778-58-6 |
詳細(xì)
|
| Fruquintinib Impurity |
呋喹替尼 |
1194506-26-7 |
詳細(xì)
|
| Isavuconazole Impurity |
艾沙康唑雜質(zhì)24 |
1176988-44-5 |
詳細(xì)
|
| Nicorandil Impurity 4 |
尼可地爾雜質(zhì) |
1798026-96-6 |
詳細(xì)
|
| Levosimendan Impurity |
左西孟旦雜質(zhì)8 |
274263-65-9 |
詳細(xì)
|
| Tamoxifen N-oxide |
他莫昔芬 N-氧化物 |
75504-34-6 |
詳細(xì)
|
| Tafamidis Impurity |
4-(3,5-二氯苯甲酰胺)-3-羥基苯甲酸 |
1184581-58-5 |
詳細(xì)
|
| Miglitol |
米格列醇 |
72432-03-2 |
詳細(xì)
|
| Fluticasone Carboxylic Acid |
氟米松酸 |
28416-82-2 |
詳細(xì)
|
| Pravastatin Impurity |
普伐他汀類酯 |
85956-22-5 |
詳細(xì)
|
| Levothyroxine Impurity |
左旋甲狀腺素EP雜質(zhì)H |
2055-97-2 |
詳細(xì)
|
| Tinidazole EP Impurity A |
2-甲基-5-硝基咪唑 |
88054-22-2 |
詳細(xì)
|
| S-Linezolid Impurity |
(S)-N-(2-乙酰氧基-3-氯丙烷)乙酰胺 |
183905-31-9 |
詳細(xì)
|
| Calcobutrol |
考布曲鈣 |
151878-23-8 |
詳細(xì)
|
| Canagliflozin Impurity 15 |
(2S,3R,4S,5S,6R)-2-(3-((5-(4-氟苯基)-2-噻吩)甲基)-4-甲苯基)-6-(羥甲基)-2-甲氧基-2H-3,4,5-三羥基四氫吡喃 |
1358581-37-9 |
詳細(xì)
|
| Cefuroxime axetil Impurity B |
頭孢呋辛酯EP雜質(zhì)B |
97232-96-7 |
詳細(xì)
|
| Oseltamivir Impurity 60 |
奧司他韋雜質(zhì) |
204254-94-4 |
詳細(xì)
|
| Ritonavir Impurity 45 |
洛匹那韋中間體 |
220887-32-1 |
詳細(xì)
|
| Probucol Impurity 22 |
4-溴-2,6-二叔丁基苯酚 |
1139-52-2 |
詳細(xì)
|
| Granisetron Impurity M |
7-羥基格拉司瓊 |
133841-15-3 |
詳細(xì)
|
| Vinpocetine impurity C |
Vinpocetine impurity C |
70155-05-4 |
詳細(xì)
|
| Palonosetron Impurity E(Hydrochloride) |
鹽酸帕洛諾司瓊雜質(zhì)1 |
135729-55-4 |
詳細(xì)
|
| Amiodarone Impurity 14 |
2-丁基苯并呋喃 |
4265-27-4 |
詳細(xì)
|
| rac-Phenylephrine EP Impurity D |
外消旋芐基去氧腎上腺素 |
1159977-09-9 |
詳細(xì)
|
| Metaraminol bitartrate |
重酒石酸間羥胺 |
33402-03-8 |
詳細(xì)
|
| 9-Propenyladenine |
9-丙烯腺嘌呤 |
1446486-33-4 |
詳細(xì)
|
| Roxithromycin Impurity |
羅紅霉素雜質(zhì)D |
134931-00-3 |
詳細(xì)
|
| Naloxone EP Impurity C |
納洛酮雜質(zhì)3 |
2139253-68-0 |
詳細(xì)
|
| Aceclofenac EP Impurity I |
1-(2,6-二氯苯基)-1,3-二氫-2H-吲哚-2-酮 |
15362-40-0 |
詳細(xì)
|
| Elagolix Impurity |
2,4(1H,3H)-Pyrimidinedione, 3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl- |
2354391-45-8 |
詳細(xì)
|
| Dapagliflozin Impurity |
達(dá)格列凈雜質(zhì)41 |
2452300-94-4 |
詳細(xì)
|
| Loratadine Impurity 33 |
Loratadine Impurity 2 |
167891-69-2 |
詳細(xì)
|
| Imrecoxib Impurity 6 |
艾瑞昔布雜質(zhì) |
2305368-53-8 |
詳細(xì)
|
| Betahistine Impurity 22 |
4-(1,1-二甲基乙基)-3,5-環(huán)己二烯-1,2-二酮 |
1129-21-1 |
詳細(xì)
|
| Indobufen Impurity 10 |
2-(3-Aminophenyl)butyric acid |
21762-24-3 |
詳細(xì)
|
| Atorvastatin Impurity C |
阿托伐他汀鈣雜質(zhì)C |
693793-53-2 |
詳細(xì)
|
| (E)-Aztreonam |
（E）-氨曲南 |
99341-02-3 |
詳細(xì)
|
| Olodaterol Impurity 43 |
1-(2-methoxyphenyl)-2-methylpropan-2-amine |
343855-95-8 |
詳細(xì)
|
| Naltrexone EP Impurity B |
14-羥基二氫降嗎啡酮 |
33522-95-1 |
詳細(xì)
|
| Baclofen Impurity 21 |
巴氯芬雜質(zhì)24 |
52977-95-4 |
詳細(xì)
|
| Vildagliptin Impurity 72 |
維格列汀雜質(zhì) |
79108-51-3 |
詳細(xì)
|
| Atracurium Impurity 43 |
S-四氫罌粟堿 |
4747-98-2 |
詳細(xì)
|
| Beclometasone Impurity 20 |
倍氯米松雜質(zhì)20 |
1192597-17-3 |
詳細(xì)
|
| Chlorpheniramine maleate impurity C reference |
氯苯那敏相關(guān)物質(zhì)C |
22630-25-7 |
詳細(xì)
|
| Rasagiline Impurity 22 |
N-芐基丙-2-炔-1-胺 HCL |
1197-51-9 |
詳細(xì)
|
| Lusutrombopag Impurity 11 |
(R)-(E)-3-(2,6-dichloro-4-{4-[2-methyloxy-3-(1-hexyloxyethyl)phenyl]thiazol-2-ylcarbamoyl}phenyl)-2-methylacrylic acid |
1110767-77-5 |
詳細(xì)
|
| Crisaborole Impurity 8 |
Benzamide, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
1187188-59-5 |
詳細(xì)
|
| Tafluprost Impurity G |
他氟前列素雜質(zhì)3 |
2920059-96-5 |
詳細(xì)
|
| Sitagliptin Impurity 44 |
N-[(2Z)-哌嗪-2-亞基]-2,2,2-三氟乙酰肼 |
763105-70-0 |
詳細(xì)
|
| Bupropion Impurity 15 |
3-氯苯甲酸 |
535-80-8 |
詳細(xì)
|
| Saxagliptin Impurity 5 |
沙格列汀 |
1564265-96-8 |
詳細(xì)
|
| Ilaprazole Impurity 5 |
2-[[(4-甲氧基-3-甲基-2-吡啶基)甲基]硫基]-6-(1H-吡咯-1-基)-1H-苯并咪唑 |
172152-35-1 |
詳細(xì)
|
| Pirarubicin Impurity 1 |
吡柔比星 |
72496-41-4 |
詳細(xì)
|
| Silagilan EP Impurity E |
D-鹽酸司來(lái)吉蘭 |
4528-51-2 |
詳細(xì)
|
| Adamantane Impurity 2 |
金剛烷雜質(zhì)10 |
2460757-92-8 |
詳細(xì)
|
| Furosemide EP Impurity A |
異呋塞米 |
4818-59-1 |
詳細(xì)
|
| Ozagrel Impurity G |
奧扎格雷酯 |
866157-50-8 |
詳細(xì)
|
| Loxoprofen Impurity O |
布洛芬雜質(zhì)52 |
67381-50-4 |
詳細(xì)
|
| Sildenafil EP Impurity D |
西地那非雜質(zhì)D |
1357931-55-5 |
詳細(xì)
|
| Argatroban impurity G |
阿加曲班雜質(zhì)7 |
188659-43-0 |
詳細(xì)
|
| Octreotide EP Impurity I |
奧曲肽雜質(zhì)1 |
83795-61-3 |
詳細(xì)
|
| Butenafine Impurity 9 |
Butenafine Impurity 11 |
1526530-79-9 |
詳細(xì)
|
| Vortioxetine Impurity 46 |
Vortioxetine Impurity 52 |
2476761-84-7 |
詳細(xì)
|
| Diacerein EP Impurity H |
1,8-二羥基-3-(羥甲基)蒽醌三醋酸酯 |
25395-11-3 |
詳細(xì)
|
| Benzoylmetronildazole |
苯酰甲硝唑 |
13182-89-3 |
詳細(xì)
|
| malic acid Nemonoxacin Impurity 30 |
1-環(huán)丙基-7-氟-8-甲氧基-4-氧代-1,4-二氫喹啉-3-甲酸 |
221221-16-5 |
詳細(xì)
|
| Flutamide EP Impurity F |
2-甲基-N-[2-硝基-5-(三氟甲基)苯基]丙酰胺 |
151262-93-0 |
詳細(xì)
|
| Ambroxol Impurity 6 |
鹽酸氨溴索雜質(zhì)11 |
2088879-81-4 |
詳細(xì)
|
| Cephalothin sodium |
頭孢噻吩鈉 |
58-71-9 |
詳細(xì)
|
| Dapoxetine impurity 14 (Hydrochloride) |
Dapoxetine Impurity 1 |
2825577-69-1 |
詳細(xì)
|
| Gadoteridol |
釓特醇 |
120066-54-8 |
詳細(xì)
|
| Duloxetine impurity 9(Oxalate) |
Duloxetine N-Methyl (R)-Isomer |
932013-45-1 |
詳細(xì)
|
| Deferasirox Impurity 8 |
地拉羅斯雜質(zhì)3 |
1688156-84-9 |
詳細(xì)
|
| Alectinib Impurity 1 |
艾樂替尼代謝雜質(zhì) |
1256585-04-2 |
詳細(xì)
|
| Teneligliptin Impurity 24 |
|
2459971-79-8 |
詳細(xì)
|